QTMeds

Drug Database Monograph

ENTYVIO 108 mg

PENDING REVIEW

Active Ingredient: VEDOLIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69607230

← Back to Prescription Analyzer